# Apodex 1.1 vs Mercury 3

> Side-by-side benchmark comparison for Apodex 1.1 and Mercury 3 across agentic, coding, multimodal, knowledge, reasoning, multilingual, and math tasks.

- Canonical page: https://benchlm.ai/compare/apodex-1-1-vs-mercury-3
- Last updated: October 19, 2026

- Shared sourced benchmarks: 1
- HTML indexing: indexable
- Ranking lane: BenchAlign v5.8

## Quick Verdict

Evidence is too thin for a benchmark verdict: Apodex 1.1 and Mercury 3 share only 1 sourced benchmark row.

## Summary

- Only 1 shared sourced benchmark row is available. That is not enough for a broad capability verdict, so this mirror does not name an overall winner.
- Apodex 1.1 has the lower published output-token price.
- Mercury 3 has the larger published context window at 1M.

## Model Snapshot

| Property | Apodex 1.1 | Mercury 3 |
|----------|----------|----------|
| Creator | Apodex | Inception |
| Type | Proprietary | Proprietary |
| Reasoning | Reasoning | Reasoning |
| Context | N/A | 1M |
| Independent public score (not head-to-head) | 50.25 | null |
| Benchmarks Covered | 10 | 8 |
| Pricing (input/output) | Pricing unavailable / Pricing unavailable | $0.10 / $0.35 |

## Category Breakdown

### Agentic

- Winner: Insufficient shared evidence
- Apodex 1.1 public-lane score: 46.9 (Estimated · #56/130)
- Mercury 3 public-lane score: Coming soon

| Benchmark | Apodex 1.1 | Mercury 3 | Winner |
|-----------|-----------|-----------|--------|
| Terminal-Bench 2.1 | 70.8% | Coming soon | Coming soon |
| HLE w/ tools | 56.1% | Coming soon | Coming soon |
| APEX-Agents | 38.5% | Coming soon | Coming soon |
| DeepSearchQA | 92.4% | 71.3% | Apodex 1.1 |
| τ³-bench results | Coming soon | 30.2% | Coming soon |
| BrowseComp+ | Coming soon | 55.18% | Coming soon |

### Coding

- Winner: Insufficient shared evidence
- Apodex 1.1 public-lane score: 42.1 (Estimated · #62/151)
- Mercury 3 public-lane score: Coming soon

| Benchmark | Apodex 1.1 | Mercury 3 | Winner |
|-----------|-----------|-----------|--------|
| Terminal-Bench 2.1 | 70.8% | Coming soon | Coming soon |
| SWE-bench Verified | 77.7% | Coming soon | Coming soon |
| DeepSWE | Coming soon | 46.3% | Coming soon |

### Reasoning

- Winner: Insufficient shared evidence
- Apodex 1.1 public-lane score: 79.5 (Unranked · 2 rankable rows)
- Mercury 3 public-lane score: Coming soon

| Benchmark | Apodex 1.1 | Mercury 3 | Winner |
|-----------|-----------|-----------|--------|
| MRCRv2 | Coming soon | 75.5% | Coming soon |

### Multimodal & Grounded

- Winner: Insufficient shared evidence
- Apodex 1.1 public-lane score: 81.1 (Unranked · 1 rankable row)
- Mercury 3 public-lane score: Coming soon

### Knowledge

- Winner: Insufficient shared evidence
- Apodex 1.1 public-lane score: 55.6 (Supported · #58/186)
- Mercury 3 public-lane score: Coming soon

| Benchmark | Apodex 1.1 | Mercury 3 | Winner |
|-----------|-----------|-----------|--------|
| HLE | 56.1% | Coming soon | Coming soon |
| FrontierScience Research | 63.3% | Coming soon | Coming soon |
| BioMysteryBench (human-difficult) | 35.3% | Coming soon | Coming soon |
| GPQA-D | Coming soon | 89.2% | Coming soon |

### Instruction Following

- Winner: Insufficient shared evidence
- Apodex 1.1 public-lane score: Coming soon
- Mercury 3 public-lane score: Coming soon

| Benchmark | Apodex 1.1 | Mercury 3 | Winner |
|-----------|-----------|-----------|--------|
| IFBench | Coming soon | 76.8% | Coming soon |
| MultiChallenge (provider reports) | Coming soon | 60.35% | Coming soon |

### Mathematics

- Winner: Insufficient shared evidence
- Apodex 1.1 public-lane score: Coming soon
- Mercury 3 public-lane score: Coming soon

| Benchmark | Apodex 1.1 | Mercury 3 | Winner |
|-----------|-----------|-----------|--------|
| IMO 2026 | 31/42 | Coming soon | Coming soon |

## FAQ

### Is there enough evidence to pick between Apodex 1.1 and Mercury 3?

Not yet. The models share only 1 sourced benchmark row, so this mirror reports the available measurements and metadata without naming a broad winner.

### What can I compare safely on this page?

Published pricing, context windows, model type, and individual shared benchmark rows are directly comparable. Independent overall scores and non-overlapping benchmark coverage are labeled separately and should not be read as a controlled head-to-head result.

## Related Comparisons

- [Apodex 1.1 vs Apodex 1.1 Mini](/compare/apodex-1-1-vs-apodex-1-1-mini)
- [Mercury 3 vs Apodex 1.1 Mini](/compare/apodex-1-1-mini-vs-mercury-3)
- [Apodex 1.1 vs Claude Opus 5.5](/compare/apodex-1-1-vs-claude-opus-5-5)
- [Mercury 3 vs Claude Opus 5.5](/compare/claude-opus-5-5-vs-mercury-3)

## Explore More

- [Apodex 1.1 profile](/models/apodex-1-1)
- [Mercury 3 profile](/models/mercury-3)
- [Compare Pricing](/llm-pricing)
- [Alternative Finder](/tools/alternative-finder)
- [LLM Selector](/tools/llm-selector)
- [Overall Rankings](/best/overall)